Over the past year, DeepIntent has seen a 25-fold increase in connected TV (CTV) ad spend from pharmaceutical marketers on its demand side platform (DSP). That eye-popping figure, provided by Chris Paquette, Founder and CEO of DeepIntent, was just one of many striking nuggets of information that dropped during the company's Innovation With Intent: A Pharma-Focused CTV Forum, which took place May 5 in New York.
Enjoying This Commentary? There's More to Love
Subscribe to MediaVillage to receive email alerts featuring the latest content on advertising, media/TV, and marketing strategies and trends, including exclusive The Myers Report research findings.